Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Wednesday it remains on track to deliver top-line Phase 3 data for its lead multiple sclerosis drug candidate, vidofludimus calcium, by the end of 2026, as ...

Breakup during illness: Sigler ended her year-long relationship with Ferrara amid worsening MS symptoms and a deepening depression. Ferrara’s support: She credited Ferrara with helping her find joy in ...

Until a couple of years ago, GQ had never aggregated the best baseball caps for men. Much like a behatted celebrity avoiding the paparazzi’s flash, the category was somehow so obvious, it had evaded ...

Take a look at some of the biggest small cap stock movers. This list is updated daily and includes premarket, during market, and after hours movers. When interest rates are low, small-cap stocks begin ...

A micro-cap stock is a stock with a total market capitalization between $300 million and $2 billion. These stocks are often smaller, less established operations. But these companies have limitless ...

Counseling and Psychological Services (CAPS) works to support the holistic development and psychological health of Bates students. CAPS is committed to provide equitable access and services to all ...

CAPS will be fully remote Monday, June 1, 2026 through Friday, June 5, 2026. Screen appointments will continue to be offered remotely and can be scheduled through your mycuhealth.colorado.edu portal ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and currently holds a Life, ...

Some mid-cap growth portfolios invest in stocks of all sizes, thus leading to a mid-cap profile, but others focus on midsize companies. Mid-cap growth portfolios target U.S. firms that are projected ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. Lands' End has produced clothing, accessories and home goods since 1963. Its offerings ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...